Causes and risk factors of death among people who inject drugs in Indonesia, Ukraine and Vietnam: findings from HPTN 074 randomized trial
Kostyantyn Dumchev(Ukrainian Institute of Public Health Policy), Irving Hoffman(Communities In Schools of Orange County), Kathryn E. Lancaster(Wake Forest University), Trần Việt Hà(University of North Carolina at Chapel Hill), Vivian F. Go(University of North Carolina at Chapel Hill), Riza Sarasvita, William C. Miller(Hennepin Healthcare Research Institute), Paul Richardson(University of Liverpool), Brett Hanscom(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Oleksandr Zeziulin(Ukrainian Institute of Public Health Policy), Zubairi Djoerban(University of Indonesia), Xu Guo(Shandong Academy of Agricultural Sciences), David S. Metzger(California University of Pennsylvania), Carl A. Latkin(Johns Hopkins University), Scott M. Rose(Family Health International 360), Estelle Piwowar‐Manning(Johns Hopkins University)
Cited by 4
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
What Is Community? An Evidence-Based Definition for Participatory Public Health
|American Journal of Public Health|2001|768
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|557